Calpains constitute a superfamily of Ca2+-dependent cysteine proteases, indispensable for various cellular processes. Among the 15 mammalian calpains, calpain 8/nCL-2 and calpain 9/nCL-4 are predominantly expressed in the gastrointestinal tract and are restricted to the gastric surface mucus (pit) cells in the stomach. Possible functions reported for calpain 8 are in vesicle trafficking between ER and Golgi, and calpain 9 are implicated in suppressing tumorigenesis. These highlight that calpains 8 and 9 are regulated differently from each other and from conventional calpains and, thus, have potentially important, specific functions in the gastrointestinal tract. However, there is no direct evidence implicating calpain 8 or 9 in human disease, and their properties and physiological functions are currently unknown. To address their physiological roles, we analyzed mice with mutations in the genes for these calpains, Capn8 and Capn9. Capn8−/− and Capn9−/− mice were fertile, and their gastric mucosae appeared normal. However, both mice were susceptible to gastric mucosal injury induced by ethanol administration. Moreover, the Capn8−/− stomach showed significant decreases in both calpains 9 and 8, and the same was true for Capn9−/−. Consistent with this finding, in the wild-type stomach, calpains 8 and 9 formed a complex we termed “G-calpain,” in which both were essential for activity. This is the first example of a “hybrid” calpain complex. To address the physiological relevance of the calpain 8 proteolytic activity, we generated calpain 8:C105S “knock-in” (Capn8CS/CS) mice, which expressed a proteolytically inactive, but structurally intact, calpain 8. Although, unlike the Capn8−/− stomach, that of the Capn8CS/CS mice expressed a stable and active calpain 9, the mice were susceptible to ethanol-induced gastric injury. These results provide the first evidence that both of the gastrointestinal-tract-specific calpains are essential for gastric mucosal defense, and they point to G-calpain as a potential target for gastropathies caused by external stresses.
The continuous or improper ingestion of irritants, including alcohol, nonsteroidal anti-inflammatory drugs (NSAIDs), and Helicobacter pylori, often leads to serious gastropathies, affecting a wide range of people. A complex gastric defense system helps protect against these threats, for example by secreting mucus. Here we report that two gastrointestinal-tract-specific calpains, calpain 8/nCL-2 and calpain 9/nCL-4, are involved in the mucosal defense against stress-induced gastropathies. Calpains are Ca2+-dependent cytosolic proteases that are indispensable for various cellular processes. Improper calpain activities can result in death or serious disorders, such as muscular dystrophies and lissencephaly, although no role for calpains in gastrointestinal diseases has been reported. Here we show that mice with mutations in the genes for calpains 8 and 9 are susceptible to alcohol-induced gastric injury. Moreover, these calpains form a stable complex, in which both molecules are essential for activity. Thus, human calpains 8 and 9 may contribute to the stomach's susceptibility to stress caused by irritants such as alcohol. Indeed, some reported human single nucleotide polymorphisms (SNPs) in these calpains are predicted to compromise their proteolytic activity. Our mutant mice provide unique animal models for potential human gastropathies caused by such SNPs.
Citation: Hata S, Abe M, Suzuki H, Kitamura F, Toyama-Sorimachi N, Abe K, et al. (2010) Calpain 8/nCL-2 and Calpain 9/nCL-4 Constitute an Active Protease Complex, G-Calpain, Involved in Gastric Mucosal Defense. PLoS Genet 6(7): e1001040. doi:10.1371/journal.pgen.1001040
Editor: Gregory S. Barsh, Stanford University School of Medicine, United States of America
Received: January 14, 2010; Accepted: June 23, 2010; Published: July 29, 2010
Copyright: © 2010 Hata et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by MEXT KAKENHI (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm) 20780106 (to SH) and 18076007 (to HS), by JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/grants.html) 19658057, 20370055 (to HS), by a Research Grant (20B-13) for Nervous and Mental Disorders from the Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/bunya/kenkyuujigyou/index.html) (to HS), and by a Takeda Science Foundation Research Grant (http://www.takeda-sci.or.jp/) (to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Calpain (Clan CA-C2, EC 220.127.116.11) is a family of intracellular Ca2+-regulated cysteine proteases found in almost all eukaryotic and some bacterial, and all the members of this family share homology in the protease domain , . Calpains play indispensable roles in biological processes including the cell cycle, apoptosis, platelet aggregation, and myoblast fusion, through the limited proteolytic cleavage of diverse substrates. Improper calpain activity often causes death or serious disorders, such as muscular dystrophies or lissencephaly –.
The mammalian calpains include both ubiquitous and tissue-specific members . The gastrointestinal-tract (GI) expresses two major ubiquitous calpains, μ- and m-calpain, and two GI-specific ones, calpain 8/nCL-2 and calpain 9/nCL-4 , . The μ- and m-calpains each form a heterodimer consisting of a distinct 80-kDa catalytic subunit (calpain 1/µCL and calpain 2/mCL, respectively) and a common 30-kDa regulatory subunit (CAPNS1/30K), which acts as a molecular chaperone for calpains 1 and 2. Calpains 8 and 9 have a typical domain structure like that of calpains 1 and 2: a regulatory N-terminal domain (domain I), protease domain (II, consisting of sub-domains IIa and IIb), C2-like Ca2+/phospholipid-binding domain (III), and penta-EF-hand (PEF) domain (IV) (Figure 1A).
(A) Schematic illustrations of mammalian calpains 1, 2, 8, and 9. Calpains 8 and 9 have a typical domain structure like calpains 1 and 2: a regulatory N-terminal pro-domain (domain I), protease domain (subdomains IIa and IIb, also called subdomains I and II), C2-like Ca2+/phospholipid-binding domain (domain III), and penta-EF-hand (PEF) domain (domain IV). CAPNS1 includes a Glycine-rich domain (domain V) and PEF domain (domain VI). Calpain 8 shows high similarity to calpain 2 over the whole molecule (amino acid identities of the full-length protein and of domains II and IV are 61.5%, 73.4%, and 51.8%, respectively). Calpain 1 (or 2) forms a heterodimer with CAPNS1 to be μ-calpain (or m-calpain). (B) Western blot analysis of mouse tissues using antibodies against calpain 8, calpain 9, calpain 1, calpain 2, and β-actin. Twenty micrograms of tissue homogenate was used for each lane except for β-actin, for which 2 µg of homogenate was used. Lanes: 1, gastric mucosa; 2, jejunum; 3, colon; 4, spleen; 5, liver; 6, kidney; 7, lung; 8, uterus; 9, heart; 10, brain. Asterisks indicate non-specific signals originating from the secondary antibody. (C) Double-immunostaining of the mouse stomach was performed using antibodies against calpain 8 (red) and calpain 9 (green). The right panel is a magnified view of the boxed area. Blue signals represent DAPI-stained nuclei. Bars, 50 µm.
Although calpains 8 and 9 share this domain structure with calpains 1 and 2, when expressed alone in cultured cells or E. coli, calpain 8 is active without CAPNS1 and forms a homo-oligomer , whereas calpain 9 requires the co-expression of CAPNS1 . Possible functions for calpain 8 in vesicle trafficking between the ER and Golgi, and those for its homologue, XCL-2, in the embryogenesis of Xenopus laevis have been reported , . Down-regulation of the calpain 9 transcript in a subset of gastric cancer patients and gastric cancer cell lines , and the association of a calpain 9 deficiency with the neoplastic transformation of naive cells have been reported , suggesting that calpain 9 plays a physiological role in the suppression of tumorigenesis.
These reports highlight that calpains 8 and 9 are regulated differently from each other and also from the conventional calpains, and thus have potentially important and specific functions in the GI that cannot be compensated for by μ- or m-calpain. However, calpains 8 and 9 have not been directly implicated in GI diseases, and their molecular properties and physiological functions have been elusive. To address these issues, we generated and analyzed mice with mutations in the genes for these calpains, Capn8 and Capn9. Our results provide genetic evidence for the involvement of calpains 8 and 9 in gastric mucosal defense. Gastric mucosal integrity depends on a complex defense system that acts in the face of a variety of irritants, including alcohol, nonsteroidal anti-inflammatory drugs (NSAIDs), and Helicobacter pylori. The continuous or improper ingestion of these irritants often leads to serious gastropathies , . Our results might therefore contribute to the development of new therapeutic strategies for human gastropathies induced by irritants.
Capn8−/− and Capn9−/− mice are susceptible to ethanol-induced gastric mucosal injury
We found that calpains 8 and 9 were predominantly expressed in the stomach and, to a lesser extent, in the digestive tract (Figure 1B). The gastric epithelium is continuously stressed by low pH and digestive enzymes, and the pit cells play a central role in mucosal protection by secreting neutral mucus and bicarbonate. The pit cells originate from proliferative progenitor cells, which are located under the pits and differentiate during their migration to the pits. These cells undergo continuous turnover, being killed by apoptosis or necrosis within a few days, to achieve homeostasis of the gastric mucosa . The localization of calpains 8 and 9 overlapped, and was predominant in the apical region of the non-proliferative middle and top pit cells, as previously reported  (Figure 1C).
To examine the functions of these proteins, we generated Capn8−/− and Capn9−/− mice (Figure 2A and 2B, Figure 3A and 3B), and confirmed the absence of their gene products by western blot analysis (Figure 2C, Figure 3C, upper panels). The Capn8−/− and Capn9−/− mice were fertile and showed no gross developmental abnormalities. Histological analysis of the stomach and intestines showed no obvious morphological abnormalities, such as mucosal hypertrophy or myxasthenia (Figure 4A and 4B for the stomach).
(A) Schematic representation of the targeting vector and WT and knock-out (KO) alleles of mouse Capn8. Exons 3 to 9 are indicated by black boxes with exon numbers. The probes for Southern blotting are shown as boxes with hatched lines. The PCR primer positions for genotyping are shown by arrows. Neo, neomycin-resistance gene; DT-A, diphtheria toxin A fragment. (B) Southern blot (left) and PCR (right) analyses of genomic DNA extracted from the tail of WT (+/+), Capn8+/− (+/−), and Capn8−/− (−/−) mice. The intercrossing of heterozygous mice generated WT, heterozygous, and homozygous mice at a ratio not significantly different from the expected Mendelian ratio. M, DNA marker. (C) Western blot analysis of gastric mucosal proteins prepared from WT (+/+), Capn8+/− (+/−), and Capn8−/− (−/−) littermate mice. Twenty micrograms of sample was used for each lane. Asterisks indicate non-specific signals.
(A) Schematic representation of the targeting vector and WT and knock-out (KO) alleles of mouse Capn9. Exons 2 to 9 are indicated by black boxes with exon numbers. The probes for Southern blotting are shown as boxes with hatched lines. The PCR primer positions for genotyping are shown by arrows. Neo, neomycin-resistance gene; DT-A, diphtheria toxin A fragment. (B) Southern blot (left) and PCR (right) analyses of genomic DNA extracted from the tail of WT (+/+), Capn9+/− (+/−), and Capn9−/− (−/−) mice. Intercrossing of heterozygous mice generated WT, heterozygous, and homozygous mice at a ratio not significantly different from the expected Mendelian ratio. M, DNA marker. (C) Western blot analysis of gastric mucosal proteins prepared from WT (+/+), Capn9+/− (+/−), and Capn9−/− (−/−) mice. Twenty micrograms of sample was used for each lane. Asterisks indicate non-specific signals.
(A,B) The gastric mucosa of Capn8−/−, Capn9−/−, and WT mice was sectioned and analyzed by hematoxylin-eosin (H-E) staining (A), and periodic acid-Schiff (PAS) staining (B). Bars, 100 µm. (C) Susceptibility of WT mice to ethanol-induced gastric lesions. The indicated concentrations of ethanol were orally administered to WT mice, and the lesion index was determined (see Materials and Methods). Values are the means ± standard error (SEM). (n = 5). (D) (left) WT, Capn8−/−, and Capn9−/− mice were orally given 0% (white bars) or 40% (black bars) ethanol, and the lesion indexes were determined (see Materials and Methods). Values are means ± SEM. *, P<0.01 vs. WT; **, P<0.05 vs. WT; Not significant vs. Capn8−/− mice (***), and vs. WT (****). (right) Representative macroscopic views of the gastric mucosa of each mouse 4 hours after 40% ethanol administration are shown. Bars, 5 mm. (E) The gastric mucosa of Capn8−/−, Capn9−/−, and WT mice was sectioned and analyzed by immunostaining using antibodies for calpain 8 (red) and calpain 9 (green). Bars, 100 µm.
To evaluate the effects of the calpain 8 or 9 deficiency on stomach functions, we used an experimental gastric injury model. Ethanol has long been used to generate a hemorrhagic gastric mucosal injury in rodents . Thus, we compared the development of gastric mucosal injury after the oral administration of ethanol among wild-type (WT), Capn8−/−, and Capn9−/− mice. The administration of 40% ethanol, which induced mild or little gastric mucosal injury in WT mice (Figure 4C), caused significantly enhanced gastric mucosal injuries in the Capn8−/− and Capn9−/− mice (Figure 4D). These mice showed no significant difference under the control condition (0% ethanol), indicating that calpains 8 and 9 are involved in protecting the gastric mucosa from ethanol-induced lesions.
A complex network system functions to provide gastroprotection against gastric injury, and includes mucous production/secretion, and mucosal restitution by the pit cells . To investigate the process in which calpains 8 and 9 are involved, we examined the effect of the calpain 8 or 9 deficiency on mucous granule production and secretion by electron microscopy and mucin immunostaining in the WT, Capn8−/−, and Capn9−/− mouse stomach. To monitor the early response in the pit cells, the stomachs were examined before and 1 hour after the administration of 40% ethanol. Consistent with the results shown in Figure 4B, there was no marked difference in granule formation among the WT, Capn8−/−, and Capn9−/− mouse stomachs before ethanol administration (Figure 5A, a–c). After the administration, these mouse stomachs showed neither a marked difference in appearance (Figure 5A, d–f) nor a significant difference in granule numbers (Figure 5B). The expression pattern of mucin-5AC (Muc5AC), a major component of the mucous secreted from the pit cells, did not differ markedly either (Figure 5C). These results indicated that calpains 8 and 9 do not function in granule production or secretion, and suggested that they are probably involved in the restitution of the mucosa by the pit cells. Further studies, however, are required to elucidate the function of calpains 8 and 9 in gastroprotection.
(A) Electron micrographs of the pit cells of WT, Capn8−/−, and Capn9−/− mice before (a–c) and after (d–f) ethanol administration. The gastric lumen is at the top of each photograph. MG, mucous granule; N, nuclei. Bars, 2 µm. (B) Comparison of the number of mucous granules per pit cell for WT, Capn8−/−, and Capn9−/− mice before (white bars) and after (black bars) ethanol administration. Top-pit (fully differentiated) cells randomly selected from stomach samples were analyzed for each experimental group (n = 45, 41, and 44 for the WT, Capn8−/−, and Capn9−/− mouse stomach groups before ethanol administration, and n = 36, 41, and 42 for those groups after the administration, respectively). The sum of the mucous granules divided by the number of cells analyzed was defined as the average number of granules per cell. Each mean value was standardized to that for the WT group before ethanol administration, which was defined as 100%. Values are means ± SEM. (C) Immunostaining of WT, Capn8−/−, and Capn9−/− mouse stomachs before (a–c) and after (d–f) ethanol administration using an antibody for Muc5AC (green). Bars, 50 µm.
Calpains 8 and 9 form a protease complex
The effect of Capn8−/− and Capn9−/− on other calpain expressions was analyzed. Surprisingly, a significant decrease in calpain 9 accompanied the loss of calpain 8 in Capn8−/− mice, and similarly, calpain 8 was decreased in Capn9−/− mice; in contrast, calpains 1 and 2 were unaltered in the mice of any genotype (Figure 2C, Figure 3C). Consistent with these observations, immunohistochemistry also showed that calpains 9 and 8 were both downregulated in the stomachs of Capn8−/− or Capn9−/− mice (Figure 4E). Reverse transcribed-polymerase chain reaction (RT-PCR) analysis showed that the calpain 8 transcript in Capn9+/− and Capn9−/− mice and the calpain 9 transcript in Capn8+/− and Capn8−/− mice were comparable to their level in WT mice (Figure 6A), indicating that the observed down-regulation was at the protein level. Immunoprecipitation using lysate prepared from WT gastric mucosa co-precipitated calpains 8 and 9 (Figure 6B, lanes 2 and 5), whereas neither calpain 2 nor CAPNS1 was co-precipitated with calpain 9 (lane 5). These observations indicated that calpains 8 and 9 form a complex in vivo.
(A) RT-PCR analysis of calpains 8 and 9 mRNA in the WT, Capn8+/−, Capn8−/−, Capn9+/−, and Capn9−/− gastric mucosa using primer pairs: calpain 8-5′/-3′ for calpain 8, calpain 9-5′/-3′ for calpain 9, and β-actin-5′/-3′ (see Table 2). (B) Gastric mucosal homogenate was immunoprecipitated without (lane 3) or with anti-calpain 8 (lane 2), anti-calpain 9 (lane 5), or absorbed-anti-calpain 9 (lane 6) antibodies, and subjected to western blotting using anti-calpain 8, anti-calpain 9, or anti-m-calpain (for calpain 2 and CAPNS1) antibodies. Lanes 1 and 4, 2% of the input used for immunoprecipitation. (C) Elution profile of the gastric mucosal proteins of WT, Capn8−/−, and Capn9−/− mice from a Superdex 200 gel filtration column (solid line, A280). Fractions were subjected to western blotting using anti-calpain 8, anti-calpain 9, or anti-calpain 2 antibodies (lower panels). Asterisks indicate non-specific signals. (D) Gastric mucosal homogenates from WT (lanes 1–8) and Capn8−/− (lanes 9–12) mice were incubated with or without Ca2+ and inhibitors (CSTN, recombinant human calpastatin domain 1 fragment; E64, E64c). The samples were subjected to western blotting using anti-calpain 8 (lanes 1–4) or anti-calpain 9 (lanes 5–12) antibodies. Open arrowheads and asterisks indicate proteolytic fragments of calpain 9 and non-specific signals, respectively. (E) Mouse calpain 8 (lanes 1–4) was co-expressed with empty vector (lanes 1 and 3) or mouse calpain 9 (lanes 2 and 4) in COS7 cells, and mouse calpain 9 (lanes 5–8) was co-expressed with empty vector (lanes 5 and 7) or mouse calpain 8 (lanes 6 and 8). Soluble lysates (sup) were recovered by ultracentrifugation of the total lysates (total) of the treated COS7 cells. The same amounts of lysate were subjected to western blot analysis using anti-calpain 8 (lanes 1–4) or anti-calpain 9 (lanes 5–8) antibodies.
To investigate the nature of this complex, homogenate prepared from WT gastric mucosa was subjected to gel filtration column chromatography. Western blot analysis of the fractions revealed that calpains 8 and 9 were co-eluted with a single peak near the 177-kDa marker, whereas calpain 2 was eluted with a single peak between the 67- and 177-kDa markers, which corresponds to the molecular weight (MW) of m-calpain (calpain 2+CAPNS1, 110 kDa) (Figure 6C, WT). In contrast, in the homogenate from the Capn8−/− gastric mucosa, calpain 9, at much lower levels than in WT, showed an elution pattern similar to that of calpain 2 (“Capn8−/−”), as did calpain 8 in the Capn9−/− gastric mucosa (“Capn9−/−”), indicating that the residual calpain 9 does not form a homodimer without calpain 8, and vice versa.
Calpains 8 and 9 are molecular chaperones for each other
Next, homogenate prepared from the Capn8−/− gastric mucosa was incubated with or without Ca2+. In WT mice, calpains 8 and 9 showed Ca2+-dependent autolysis (Figure 6D, lanes 1 and 5), which was inhibited by the addition of a recombinant calpastatin domain 1 fragment, one of four inhibitory units of an endogenous calpain-specific inhibitor protein, or of E64c, a more general cysteine protease inhibitor (lanes 3, 4, 7, and 8). As seen for calpain 2 in Capns1−/− mouse embryos, which are deficient in CAPNS1 , the amount of calpain 9 in the Capn8−/− mice was significantly decreased, as described above, and it lacked proteolytic activity, even in the presence of Ca2+ (lane 9). Consistent with this finding, in transfected COS7 cells, calpains 8 and 9 were more abundant in the supernatant fraction when both were co-expressed than when either molecule was expressed singly (Figure 6E, lanes 3, 4, 7, and 8). These results indicated that calpains 8 and 9 function as molecular chaperones for each other in the complex, like CAPNS1 does for calpain 2.
Calpain 8 protease activity is essential for gastric mucosal defense
Recently, calpain 6, a unique non-proteolytic member of the mammalian calpain family with a naturally inactive catalytic site, was reported to interact with microtubules and microfilaments and to be involved in their regulation . Thus, calpain 6 is likely to function as a structural element. To examine whether the calpain 8/9 complex functions as a structural component or protease, we generated and analyzed calpain 8:C105S knock-in (Capn8CS/CS) mice, which express proteolytically inactive but structurally intact calpain 8 (Figure 7A and 7B). Like the Capn8−/− mice, Capn8CS/CS mice were fertile with no apparent abnormalities. Notably, the protein levels of calpains 8 and 9 as well as of calpains 1 and 2 were unaltered between the WT and Capn8CS/CS mice (Figure 6C). In the homogenate of the Capn8CS/CS gastric mucosa, calpain 9 showed Ca2+-dependent autolysis, which was inhibited by the calpastatin domain 1 fragment or E64c (Figure 7D, lanes 13–16). Notably, the calpain 8:C105S protein was almost completely proteolyzed Ca2+-dependently (Figure 7D, lane 5). This finding strongly suggests that, in the calpain 8/9 complex, not only intramolecular autolysis but also intermolecular proteolysis takes place, as in the activation of μ- and m-calpains, which involves the proteolysis of CAPNS1 . At present, it cannot be completely excluded that μ- and/or m-calpain in the same fraction proteolyzed the calpain 8:C105S protein.
(A) Schematic representation of the targeting vector and WT, CS-neo, and CS alleles of mouse Capn8. Exons 3 to 7 are indicated by black boxes with exon numbers. The 3′-probe for Southern blotting is shown as a box with hatched lines. The PCR primer positions for the genotyping of Cre-recombinant mice are shown by arrows. Neo, neomycin-resistance gene; DT-A, diphtheria toxin A fragment. (B) (left) Southern blot analysis of genomic DNA extracted from the tail of WT, Capn8CSneo/+ (CSneo/+), and Capn8CSneo/CSneo (CSneo/CSneo) mice. (right) PCR analysis of genomic DNA extracted from the tail of WT (+/+), Capn8CS/+ (CS/+), and Capn8CS/CS (CS/CS) mice. Intercrossing of heterozygous mice generated wild-type, heterozygous, and homozygous mice at a ratio not significantly different from the expected Mendelian ratio. M, DNA marker. (C) Western blot analysis of the gastric mucosal homogenates (20 µg) prepared from WT and Capn8CS/CS (CS/CS) mice. (D) The gastric mucosal homogenates from WT (lanes 1–4 and 9–12) and Capn8CS/CS (lanes 5–8 and 13–16) mice were incubated with or without Ca2+ and inhibitors, as indicated (CSTN, recombinant human calpastatin domain 1 fragment; E64, E64c). The samples were subjected to western blot analysis using an anti-calpain 8 (lanes 1–8) or anti-calpain 9 (lanes 9–16) antibody. Open arrowheads and asterisks indicate proteolytic fragments of calpain 9 and non-specific signals, respectively. (E) (left) WT and Capn8CS/CS mice were orally given 40% ethanol, and the lesion index was determined. Values are the means ± SEM. *, P<0.05 vs. WT. (right) Representative macroscopic views of the gastric mucosa of WT and Capn8CS/CS mice 4 hours after ethanol administration. Bars, 5 mm.
To our surprise, the oral administration of 40% ethanol significantly induced gastric injury in Capn8CS/CS mice (Figure 7E), with a severity comparable to that in Capn8−/− and Capn9−/− mice. This result indicated that the proteolytic activity of calpain 8 is essential for gastric mucosal defense, even though inactive calpain 8 forms a stable complex containing proteolytically active calpain 9.
The functions of tissue-specific calpains are most likely relevant to the tissues expressing them; therefore, there is an advantage to studying them over ubiquitous calpains, which are indispensable in embryogenesis or show functional redundancy , , . For example, skeletal muscle-specific calpain 3/p94 is a product of the gene responsible for limb-girdle muscular dystrophy type 2A (LGMD2A) , demonstrating that the inactivation of tissue-specific calpains is a potential direct strategy for understanding some of the calpain functions. In this study, we investigated the gastrointestinal-tract-specific calpains by using gene targeting in mice, and obtained evidence that calpains 8 and 9 play a protective role in the gastric mucosa by forming a protease complex. This is the first report of the in vivo significance and properties of the gastrointestinal-tract-specific calpains.
The ethanol stress-dependent phenotype of the Capn8−/− and Capn9−/− mice and limited localization of calpains 8 and 9 suggest that these mutant mice have mild defects in their pit cells, and/or in their stress-induced immediate response for mucosal protection. So far, growth factors, heat shock proteins, and gastric mucosal blood flow have been reported to be important for gastric mucosal protection and restitution –. Notably, here we found that calpains 8 and 9 are also important for these functions, illuminating a novel research area for gastroenterology.
It is striking that calpains 8 and 9 form a complex in which both proteins are essential for stability and activity. This finding explains the co-localization of calpains 8 and 9 in the stomach, and why Capn8−/− and Capn9−/− mice showed the same phenotype without functional compensation between calpains 8 and 9. The MW of the complex (∼180 kDa) indicates that it contains at most one molecule each of calpain 8 and 9, although the possibility of one or more small additional subunits cannot be eliminated. It is curious that only calpains 8 and 9 form this complex, despite the highly similar overall amino acid sequences among calpain 1, calpain 2, calpain 8, and calpain 9. Recently, a comparison of the 3D structures of calpain 1, calpain 2, and calpain 9 revealed divergent mechanisms for their activation and regulation . Calpains 8 and 9 probably evolved to have local structures specific for binding each other. We propose calling the enzyme entity composed of calpains 8 and 9 in the stomach, “Gastric calpain” (“G-calpain”), a novel “hybrid” type of calpain enzyme composed of different calpain catalytic subunits, which has never been reported for any kind of calpain.
As shown in Table 1, in the NCBI single nucleotide polymorphism (SNP) database, 3 and 15 missense polymorphisms in calpains 8 and 9 were found, respectively. Among these SNPs, the calpain 8:A136V, calpain 9:A102V, and calpain 9:R277W polymorphisms represent changes in amino acid residues that are highly conserved among calpain family members. Moreover, the amino acid positions of calpain 8:A136 and calpain 9:R277 correspond to calpain 3:A160 and calpain 3:R357, respectively, the sites of the reported LGMD2A pathogenic mutations, calpain 3:A160Q/P and calpain 3:R357W. These findings strongly suggest that some of these SNPs compromise the proteolytic activity of calpain 8 or calpain 9. Frame-shift SNPs are also expected to drastically change the nature of calpain 9 by truncating the C-terminal EF-hand motif(s). Therefore, it is tempting to speculate that these SNPs are related to a susceptibility to human gastropathies caused by irritants such as alcohol. It should be noted that R277W SNP shows a global frequency of 0.006, which means that one out of every 28,000 people probably has only inactive calpain 9 due to homozygous R277W alleles.
What is the physiological significance of the calpain 8/9 complex formation? Capn8CS/CS mice, in which the calpain 9 protein level and proteolytic activity were unaltered, also showed a susceptibility to ethanol-induced gastric injury. This finding indicates that the activity of calpain 9 alone and inactive calpain 8 with its proteolyzed fragments were insufficient for specific functions of the gastric pit cells, and leads to a new model for calpain activation in the G-calpain system (Figure 8). In this model, increased intracellular Ca2+ induces the activation of calpains 8 and 9 at the same time and location, which is specifically required for pit-cell function, in addition to the conventional calpain system. Identification of the in vivo substrates for G-calpain is an important issue for future research. In this regard, one promising candidate is β-COP , , a subunit of the COP-I vesicle coatomer complex, which is involved in Golgi-endoplasmic reticulum membrane trafficking. We previously identified β-COP as an in vitro substrate for calpain 8 . On the other hand, we also showed that G-calpain is not involved in mucus production or secretion (see Figure 5), which suggested that G-calpain functions in the mucosal restitution by pit cells after gastric injury. Consistent with this idea, conventional calpains are involved in cell migration . Whether or not β-COP is relevant to this process is a very important issue to be elucidated in the future.
(Upper) In the stomach pit cells, in addition to the conventional μ- and m-calpains, G-calpain is predominantly expressed. To be activated by Ca2+, G-calpain requires both catalytic subunits, which intramolecularly and intermolecularly autolyze, probably dissociating from each other. The proteolytic activity of at least calpain 8 is essential for the physiological function of G-calpain, that is, stress-induced gastric mucosal protection. We previously found that calpain 8, when transiently expressed without calpain 9 in cultured cells or in E. coli, forms homo-oligomers . Although the physiological significance of this homo-oligomerization is unclear, it may play a role in modulating the activation of G-calpain under certain conditions. (Lower) In contrast, conventional μ- and m-calpains require a regulatory subunit, CAPNS1, but not other catalytic subunits, to be Ca2+-dependently activated to proteolyze their substrates, although it remains controversial whether or not their activation involves the dissociation of subunits, as illustrated here –. Since the stomach is under frequent stress, an extra calpain system in addition to the conventional one may have been required to respond swiftly to stresses.
In humans, mutations of CAPN3 were shown to be responsible for muscular dystrophy by forward genetics , and an intron polymorphism of CAPN10 was reported to be associated with type 2 diabetes by statistical genetics . This is the first report in which disease-responsible calpain genes were identified by reverse genetics. Our results also identify CAPN8 and CAPN9 as promising targets for various stress-induced human gastropathies. Our mutant mice described here represent potentially helpful tools for studying such diseases.
Materials and Methods
All procedures using experimental animals were approved by the Experimental Animal Care and Use Committee of Rinshoken, and the animals were treated according to the committee's guidelines. C57BL/6 and ICR mice were purchased from Nihon CLEA. EIIa-Cre transgenic mice  were purchased from the Jackson Laboratory.
Homologous recombination of embryonic stem (ES) cells
Mouse BAC clones containing Capn8 or Capn9 were purchased from Children's Hospital Oakland Research Institute. The genomic fragments used were amplified by PCR using Phusion high fidelity DNA polymerase (Finnzymes). Targeting vectors for Capn8−/− and Capn9−/− mice were constructed by replacing exon 3, which includes the codon for the active-site residue Cys, with a neomycin-resistance gene (neo) cassette (Figure 2A, Figure 3A). For the calpain 8:C105S knock-in (Capn8CS/CS) mice, Cys105 of calpain 8 was mutated to serine (Cys105Ser). A neo cassette flanked by loxP was inserted at intron 2 (Figure 7A). For the Capn8−/− mice, a 3.2-kbp fragment containing intron 2, and a 6.8-kbp fragment containing exons 4 to 8 were amplified and used as the 5′-arm and 3′-arm, respectively. For the Capn9−/− mice, a 4.2-kbp fragment containing exon 2, and an 8.6-kbp fragment containing exons 4 to 7 were used. For the Capn8CS/CS mice, a 4.3-kbp fragment containing intron 2, and a 2.1-kbp fragment containing exons 3 to 5 were used. For negative selection, a diphtheria toxin A fragment with an MC1 promoter  was attached downstream of the 3′ arms. The targeting vectors for Capn8−/− and Capn9−/− mice were linearized using SalI and electroporated into the C57BL/6N-derived ES cell line, RENKA . For the Capn8CS/CS mice, the targeting vector was linearized using NotI and electroporated into TT2 ES cells . The G418-resistant clones were screened, and the correctly targeted clones were confirmed by Southern blotting (Figure 2B, Figure 3B, Figure 7B). For Southern blotting, genomic DNA was digested with the appropriate restriction enzymes, and hybridized with the 32P-labeled probes shown in Figure 2A, Figure 3A, and Figure 7A.
Generation of Capn8−/−, Capn9−/−, and Capn8CS/CS mice
The generation of chimeric males was achieved by the aggregation method for the Capn8−/− and Capn9−/− mice, and by the injection method for the Capn8CS/CS knock-in mice , . Briefly, 8-cell-stage embryos were flushed out of the fallopian tubes of ICR females. In the aggregation method, the embryos were treated with acid Tyrode's buffer (Sigma) to remove the zona pellucida, and each embryo was placed in a depression created by an aggregation needle (Biological Laboratory Equipment) in a 35-mm-diameter culture dish containing M16 medium (Sigma). Five to ten positive ES cells were then placed adjacent to each embryo in the depression. In the injection method, five to ten positive ES cells were injected into each 8-cell-stage embryo. After an overnight culture, the ES cell-containing embryos that developed to the blastocyst stage were transplanted into the uterus of pseudo-pregnant ICR females. Germline transmitted chimeric males were crossed with C57BL/6N females for the Capn8−/− and Capn9−/− mice, and with C57BL/6J females for the calpain 8 CS knock-in mice, to generate heterozygotes. For the Capn8CS/CS mice, the heterozygotes were crossed with EIIa-Cre transgenic mice, in which Cre recombinase is expressed from the zygote stage, to remove the neo cassette from intron 2. The resultant mice were then backcrossed with C57BL/6J mice for 10 generations. The PCR primers used for genotyping are listed in Table 2. The mice were housed in pathogen-free facilities at our institute.
Antibodies and reagents
The anti-calpain 8 domain III polyclonal antibody (ab28215), anti-calpain 9 monoclonal antibody (3A6), anti-calpain 9 polyclonal antibody (V-18), anti-Muc5AC monoclonal antibody (clone 45M1), and anti-β-actin monoclonal antibody (clone AC-15) were purchased from Abcam, Abnova, Santa Cruz, Thermo Scientific, and Sigma, respectively. The anti-calpain 2 monoclonal antibody (4B9F1), anti-m-calpain polyclonal antibody, and anti-calpain 1 polyclonal antibody were kind gifts from Dr. Seiichi Kawashima, Dr. Hideo Sugita, and Dr. Gen Kudo, respectively. Protease inhibitors (a recombinant human calpastatin domain 1 fragment (TaKaRa, No. 7316), E64c, PMSF, and pepstatin A) and chemical reagents were purchased from TaKaRa, Peptide Institute, Sigma, and Kanto Chemical.
Stomach and intestine samples were fixed and immunostained as described previously , and the signals were detected by LSM510 META confocal microscopy (Zeiss). For H-E staining, the sections were stained with Mayer's hematoxylin, followed by eosin staining. For PAS staining, the sections were pre-treated with 0.5% periodic acid and stained with Schiff's reagent (Polysciences). H-E- and PAS-stained sections were mounted with Mount-Quick (Daido Sangyo), and viewed with a BX60 microscope (Olympus).
The gastric ulcerogenic response was examined as described previously, with some modifications , . Mice were fasted for 20 hours before the experiment, but were allowed free access to water. The mice were given 5 ml/kg body weight of 40% ethanol or water (0% ethanol) orally. After 4 hours, the mice were sacrificed by cervical dislocation. The stomachs were removed, opened along the grate curvature, and rinsed gently in PBS for the macroscopic evaluation of gastric lesions. The severity of gastric lesions was scored according to the following lesion index: 0 = no lesion; 1 = punctuate lesion; 2 = short linear ulcer (less than 2 mm); 3 = medium linear ulcer (2–4 mm); 4 = long linear ulcer (more than 4 mm). The sum of the total scores divided by the number of samples was defined as the mean lesion index.
To evaluate the involvement of calpains 8 and 9 in mucous formation and secretion, six experimental groups were prepared, corresponding to WT, Capn8−/−, and Capn9−/− mice before or after 40% ethanol administration. Two mice were used for each experimental group. The mice were sacrificed 1 hour after ethanol administration, and stomach samples were prepared as described above, and subjected to electron microscopy and immunostaining.
For electron microscopy, the stomach samples were fixed with 0.1 M sodium phosphate buffer (pH 7.4) containing 4% paraformaldehyde and 1% glutaraldehyde. After a 2-hour fixation at 4°C, the samples were washed with 0.1 M sodium phosphate buffer (pH 7.4), post-fixed in the same buffer containing 1% osmium tetroxide for 60 min, dehydrated with a graded ethanol series, and embedded in Epon 812 (Shell Chemicals). Semi-thin sections stained with toluidine blue were prepared, to verify the orientation of the sections by light microscopy. Ultra-thin sections were then prepared and mounted on copper grids, electron-stained with uranyl acetate and lead citrate, and examined with a JEM 1230 electron microscope (Japan Electron Optics Laboratory) at an accelerating voltage of 80 kV.
Mouse gastric mucosa was scraped from the underlying muscularis layer, homogenized in the appropriate buffer, and subjected to immunoprecipitation, incubation assay, or gel-filtration analyses. For immunoprecipitation, the gastric mucosal homogenate from a WT, Capn8−/−, or Capn9−/− mouse in lysis buffer (10 mM Tris/Cl (pH 7.5), 5 mM EDTA, 150 mM NaCl, 0.5% NP-40, 0.2 mM PMSF, 5 µM pepstatin A, and 25 µM leupeptin) was prepared and immunoprecipitated with or without an anti-calpain 8 antibody, anti-calpain 9 (V-18) antibody, or antigen absorbed-anti-calpain 9 (V-18) antibody for 16 hours at 4°C, followed by the addition of protein G. After the bound protein G was washed five times with the lysis buffer, the immunoprecipitated proteins were eluted with 0.2 M Glycine (pH 2.7) and mixed with SDS sample buffer. For the incubation assay, the gastric mucosal homogenate from a WT, Capn8−/−, or Capn8CS/CS mouse was prepared in TED buffer (10 mM Tris/Cl (pH 7.5), 1 mM EDTA, 1 mM dithiothreitol) containing 0.2 mM PMSF and 5 µM pepstatin A. The homogenate (20 µg) was incubated at 30°C for 30 min in the absence or presence of 5 mM Ca2+ with or without 6 µM recombinant human calpastatin domain 1 fragment or 80 µM E64c. The reaction was stopped by adding SDS sample buffer. The protein samples were subjected to Western blot analysis with the appropriate antibodies. For the gel filtration analysis, the gastric mucosal homogenate from a WT, Capn8−/−, or Capn9−/− mouse was prepared in TED buffer containing 0.2 mM PMSF, 5 µM pepstatin A, and 25 µM leupeptin. The homogenate (1 mg) was applied to a Superdex 200 10/30 column (GE Healthcare) equilibrated with elution buffer (150 mM NaCl in TED buffer). COS7 cells were transfected by electroporation, as described previously .
For RT-PCR analysis, the total RNAs were extracted from the gastric mucosa of WT, Capn8+/−, Capn8−/−, Capn9+/−, and Capn9−/− mice using a TRIzol reagent (Invitrogen), reverse-transcribed to make the first-strand cDNA, using a First Strand cDNA Synthesis kit (Amersham Bioscience) according to the manufacturer's instructions, and subjected to PCR using ExTaq (TaKaRa). Mouse β-actin was used as an internal control. The primers used are listed in Table 2.
Differences between two mean values were analyzed by Student's t-test, and P values<0.05 were defined as statistically significant.
We thank Dr. Taeko Do-hi (International Medical Center of Japan), Dr. Hiroyuki Kawahara (Tokyo Metropolitan University), Dr. Shigeo Murata, Dr. Tatsuya Maeda (University of Tokyo), Dr. Tomoki Chiba (Tsukuba University), Dr. Choji Taya, Dr. Hiromichi Yonekawa, Dr. Keiji Tanaka (Rinshoken), Dr. Koichiro Wada (Osaka University), Dr. Toshiyuki Takeuchi (Gunma University Graduate School of Medicine), Dr. Koichi Suzuki (University of Tokyo Professor Emeritus), and all the laboratory members for their experimental support and valuable discussions. We dedicate this paper to the memory of Dr. Koichi Suzuki, who passed away on April 20, 2010. We will always be grateful for his mentorship and generosity.
Conceived and designed the experiments: S Hata. Performed the experiments: S Hata, H Suzuki, F Kitamura. Analyzed the data: S Hata, H Sorimachi. Contributed reagents/materials/analysis tools: M Abe, N Toyama-Sorimachi, K Abe, K Sakimura. Wrote the paper: S Hata, H Sorimachi.
- 1. Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83: 731–801.
- 2. Suzuki K, Hata S, Kawabata Y, Sorimachi H (2004) Structure, activation, and biology of calpain. Diabetes 53: S12–18.
- 3. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26: 163–175.
- 4. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, et al. (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81: 27–40.
- 5. Russo I, Oksman A, Vaupel B, Goldberg DE (2009) A calpain unique to alveolates is essential in Plasmodium falciparum and its knockdown reveals an involvement in pre-S-phase development. Proc Natl Acad Sci USA 106: 1554–1559.
- 6. Saito K, Elce JS, Hamos JE, Nixon RA (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90: 2628–2632.
- 7. Syntichaki P, Xu K, Driscoll M, Tavernarakis N (2002) Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature 419: 939–944.
- 8. Yamada M, Yoshida Y, Mori D, Takitoh T, Kengaku M, et al. (2009) Inhibition of calpain increases LIS1 expression and partially rescues in vivo phenotypes in a mouse model of lissencephaly. Nat Med 15: 1202–1207.
- 9. Lee HJ, Sorimachi H, Jeong SY, Ishiura S, Suzuki K (1998) Molecular cloning and characterization of a novel tissue-specific calpain predominantly expressed in the digestive tract. Biol Chem 379: 175–183.
- 10. Sorimachi H, Ishiura S, Suzuki K (1993) A novel tissue-specific calpain species expressed predominantly in the stomach comprises two alternative splicing products with and without Ca2+-binding domain. J Biol Chem 268: 19476–19482.
- 11. Hata S, Doi N, Kitamura F, Sorimachi H (2007) Stomach-specific calpain, nCL-2/calpain 8, is active without calpain regulatory subunit and oligomerizes through C2-like domains. J Biol Chem 282: 27847–27856.
- 12. Lee HJ, Tomioka S, Kinbara K, Masumoto H, Jeong SY, et al. (1999) Characterization of a human digestive tract-specific calpain, nCL-4, expressed in the baculovirus system. Arch Biochem Biophys 362: 22–31.
- 13. Hata S, Koyama S, Kawahara H, Doi N, Maeda T, et al. (2006) Stomach-specific calpain, nCL-2, localizes in mucus cells and proteolyzes the β-subunit of coatomer complex, β-COP. J Biol Chem 281: 11214–11224.
- 14. Cao Y, Zhao H, Grunz H (2001) XCL-2 is a novel m-type calpain and disrupts morphogenetic movements during embryogenesis in Xenopus laevis. Dev Growth Differ 43: 563–571.
- 15. Yoshikawa Y, Mukai H, Hino F, Asada K, Kato I (2000) Isolation of two novel genes, down-regulated in gastric cancer. Jpn J Cancer Res 91: 459–463.
- 16. Liu K, Li L, Cohen SN (2000) Antisense RNA-mediated deficiency of the calpain protease, nCL-4, in NIH3T3 cells is associated with neoplastic transformation and tumorigenesis. J Biol Chem 275: 31093–31098.
- 17. Cover TL, Blaser MJ (1992) Helicobacter pylori and gastroduodenal disease. Annu Rev Med 43: 135–145.
- 18. Hawkey CJ (2000) Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 119: 521–535.
- 19. Karam SM (1999) Lineage commitment and maturation of epithelial cells in the gut. Front Biosci 4: D286–298.
- 20. Romano M, Polk WH, Awad JA, Arteaga CL, Nanney LB, et al. (1992) Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo. J Clin Invest 90: 2409–2421.
- 21. Wallace JL, Granger DN (1996) The cellular and molecular basis of gastric mucosal defense. FASEB J 10: 731–740.
- 22. Arthur JS, Elce JS, Hegadorn C, Williams K, Greer PA (2000) Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol 20: 4474–4481.
- 23. Tonami K, Kurihara Y, Aburatani H, Uchijima Y, Asano T, et al. (2007) Calpain 6 is involved in microtubule stabilization and cytoskeletal organization. Mol Cell Biol 27: 2548–2561.
- 24. Dutt P, Croall DE, Arthur JS, Veyra TD, Williams K, et al. (2006) m-Calpain is required for preimplantation embryonic development in mice. BMC Dev Biol 6: 3.
- 25. Azam M, Andrabi SS, Sahr KE, Kamath L, Kuliopulos A, et al. (2001) Disruption of the mouse μ-calpain gene reveals an essential role in platelet function. Mol Cell Biol 21: 2213–2220.
- 26. Polk WH Jr, Dempsey PJ, Russell WE, Brown PI, Beauchamp RD, et al. (1992) Increased production of transforming growth factor α following acute gastric injury. Gastroenterology 102: 1467–1474.
- 27. Vongthavaravat V, Mesiya S, Saymeh L, Xia Y, Harty RF (2003) Mechanisms of transforming growth factor-α (TGF-α) induced gastroprotection against ethanol in the rat: roles of sensory neurons, sensory neuropeptides, and prostaglandins. Dig Dis Sci 48: 329–333.
- 28. Saika M, Ueyama T, Senba E (2000) Expression of immediate early genes, HSP70, and COX-2 mRNAs in rat stomach following ethanol ingestion. Dig Dis Sci 45: 2455–2462.
- 29. Davis TL, Walker JR, Finerty PJ Jr, Mackenzie F, Newman EM, et al. (2007) The crystal structures of human calpains 1 and 9 imply diverse mechanisms of action and auto-inhibition. J Mol Biol 366: 216–229.
- 30. Eugster A, Frigerio G, Dale M, Duden R (2000) COP I domains required for coatomer integrity, and novel interactions with ARF and ARF-GAP. EMBO J 19: 3905–3917.
- 31. Rabouille C, Klumperman J (2005) Opinion: The maturing role of COPI vesicles in intra-Golgi transport. Nat Rev Mol Cell Biol 6: 812–817.
- 32. Glading A, Chang P, Lauffenburger DA, Wells A (2000) Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem 275: 2390–2398.
- 33. Lakso M, Pichel JG, Gorman JR, Sauer B, Okamoto Y, et al. (1996) Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci USA 93: 5860–5865.
- 34. Yagi T, Ikawa Y, Yoshida K, Shigetani Y, Takeda N, et al. (1990) Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection. Proc Natl Acad Sci USA 87: 9918–9922.
- 35. Mishina M, Sakimura K (2007) Conditional gene targeting on the pure C57BL/6 genetic background. Neurosci Res 58: 105–112.
- 36. Yagi T, Tokunaga T, Furuta Y, Nada S, Yoshida M, et al. (1993) A novel ES cell line, TT2, with high germline-differentiating potency. Anal Biochem 214: 70–76.
- 37. Wood SA, Pascoe WS, Schmidt C, Kemler R, Evans MJ, et al. (1993) Simple and efficient production of embryonic stem cell-embryo chimeras by coculture. Proc Natl Acad Sci USA 90: 4582–4585.
- 38. Jimenez D, Martin MJ, Pozo D, Alarcon C, Esteban J, et al. (2002) Mechanisms involved in protection afforded by L-arginine in ibuprofen-induced gastric damage: role of nitric oxide and prostaglandins. Dig Dis Sci 47: 44–53.
- 39. Pan LR, Tang Q, Fu Q, Hu BR, Xiang JZ, et al. (2005) Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer mice. Acta Pharmacol Sin 26: 1334–1338.
- 40. Zhang W, Mellgren RL (1996) Calpain subunits remain associated during catalysis. Biochem Biophys Res Commun 227: 891–896.
- 41. Pal GP, Elce JS, Jia Z (2001) Dissociation and aggregation of calpain in the presence of calcium. J Biol Chem 276: 47233–47238.
- 42. Yoshizawa T, Sorimachi H, Tomioka S, Ishiura S, Suzuki K (1995) Calpain dissociates into subunits in the presence of calcium ions. Biochem Biophys Res Commun 208: 376–383.